Dynamic 11C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: An experimental study using small animal PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 10, 2011, Pages 1876-1886

  Zhao, Songji ^a   Kuge, Yuji ^b   Yi, Min ^a   Zhao, Yan ^a   Hatano, Toshiyuki ^b   Magota, Keiichi ^a   Nishijima, Ken Ichi ^a   Kohanawa, Masashi ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Dynamic 11C MET PET; Granuloma; Inflammation; Rat; Tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHIONINE C 11; CARBON 11 METHIONINE; CARBON-11 METHIONINE; DIAGNOSTIC AGENT; METHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GLIOMA CELL; GRANULOMA; IMAGE ANALYSIS; INOCULATION; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; ANIMAL; DIFFERENTIAL DIAGNOSIS; NEOPLASM; PATHOLOGY; SCINTISCANNING; WISTAR RAT;

ANIMALS; DIAGNOSIS, DIFFERENTIAL; GRANULOMA; MALE; METHIONINE; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR;

EID: 80455155133     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1865-2     Document Type: Article

References (38)

1. Brudin LH, Valind S, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21:297-305. (Pubitemid 24106447)
2. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1647-9.
3. Ohtsuka T, Nomori H, Watanabe K, Naruke T, Orikasa H, Yamazaki K, et al. False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer. Jpn J Clin Oncol 2005;35:271-3. (Pubitemid 41444294)
4. Lorenzen J, de Wit M, Buchert R, Igel B, Bohuslavizki KH. Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy. Nuklearmedizin 1999;38:333-6.
5. Conessa C, Hervé S, Foehrenbach H, Poncet JL. FDG-PETscan in local follow-up of irradiated head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol 2004;113:628-35. (Pubitemid 39031106)
6. van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med 2004;45:695-700. (Pubitemid 47618601)
7. van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med 2006;47:150-4. (Pubitemid 46768524)
8. Jacobs AH, Dittmar C, Winkeler A, Garlip G, Heiss WD. Molecular imaging of gliomas. Mol Imaging 2002;1:309-35.
9. Kubota K, Kubota R, Yamada S, Tada M. Effects of radiotherapy on the cellular uptake of carbon-14 labeled L-methionine in tumor tissue. Nucl Med Biol 1995;22:193-8.
10. Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-92.
11. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997;38:280-7. (Pubitemid 27061613)
12. Chung JK, Kim YK, Kim SK, Lee YK, Paek S, Yeo JS, et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 2002;29:176-82.
13. Moulin-Romsée G, D'Hondt E, de Groot T, Goffin J, Sciot R, Mortelmans L, et al. Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine? Eur J Nucl Med Mol Imaging 2007;34:2082-7. (Pubitemid 350212139)
14. Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M, et al. [(11) C]Methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy. Clin Cancer Res 2004;10:1764-72. (Pubitemid 38443328)
15. Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, et al. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis. Ann Nucl Med 2007;21:331-7. (Pubitemid 47283261)
16. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, et al. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 2003;98:1056-64. (Pubitemid 36460897)
17. Yamada Y, Uchida Y, Tatsumi K, Yamaguchi T, Kimura H, Kitahara H, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 1998;39:1160-6. (Pubitemid 28326144)
18. Zhao S, Kuge Y, Kohanawa M, Takahashi T, Kawashima H, Temma T, et al. Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors. Eur J Nucl Med Mol Imaging 2007;34:2096-105. (Pubitemid 350212134)
19. Zhao S, Kuge Y, Yi M, Kohanawa M, Zhao Y, Kanegae K, et al. Dynamics of 18F-FDG uptake in experimental granulomas induced with activated macrophages: comparison with malignant tumors [abstract]. J Nucl Med 2008;49(Suppl 1):318P.
20. Zhao S, Kuge Y, Kohanawa M, Takahashi T, Zhao Y, Yi M, et al. Usefulness of 11C-methionine for differentiating tumors from granulomas in experimental rat models: a comparison with 18F-FDG and 18F-FLT. J Nucl Med 2008;49:135-41.
21. Yi M, Kohanawa M, Ozaki M, Haga S, Fujikawa K, Zhao S, et al. Mutual modulation between interleukin-10 and interleukin-6 induced by Rhodococcus aurantiacus infection in mice. Microbes Infect 2008;10:1450-8.
22. Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7. (Pubitemid 32852620)
23. Lowe VJ, DeLong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG-PETevaluation of pulmonary malignancy. J Nucl Med 1995;36:883-7.
24. Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med 2001;28:730-5.
25. Ito T, Mitui H, Udaka N, Hayashi H, Okudela K, Kanisawa M, et al. Ki-67 (MIB 5) immunostaining of mouse lung tumors induced by 4-nitroquinoline 1-oxide. Histochem Cell Biol 1998;110:589-93. (Pubitemid 28535614)
26. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-45. (Pubitemid 32207394)
27. Stöber B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L- tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 2006;33:932-9. (Pubitemid 44127443)
28. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 2003;445:529-33. (Pubitemid 36286884)
29. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 1990;70:43-77. (Pubitemid 20037281)
30. Kubota K, Matsuzawa T, Fujiwara T, Sato T, Tada M, Ido T, et al. Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with L-[methyl-11C]methionine. Jpn J Cancer Res 1989;80:778-82. (Pubitemid 20023052)
31. Iuchi T, Iwadate Y, Namba H, Osato K, Saeki N, Yamaura A, et al. Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res 1999;21:640-4. (Pubitemid 29510832)
32. Zhao S, Kuge Y, Kohanawa M, Zhao Y, Kanegae K, Seki K, et al. Usefulness of 11C-methionine in evaluating cellular proliferation and differential diagnosis of tumor and granuloma: an experimental study in comparison with 18F-FDG [abstract]. J Nucl Med 2007;48(Suppl 2):29P.
33. Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B 1992;19:183-90.
34. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982;70:550-7. (Pubitemid 12054579)
35. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-80.
36. Wang TC, Hsiao IT, Cheng YK, Wey SP, Yen TC, Lin KJ. Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging. J Neurooncol 2011. Feb. 12. [Epub ahead of print].
37. Asano M, Kohanawa M, Minagawa T, Nakane A. Reciprocal action of interferon-γand interleukin-4 promotes granulomatous inflammation induced by Rhodococcus aurantiacus in mice. Immunology 1996;88:394-9. (Pubitemid 26225163)
38. Asano M, Nakae A, Minagawa T. Endogenous gamma interferon is essential in granuloma formation induced by glycolipidcontaining mycolic acid in mice. Infect Immun 1993;61:2872-8. (Pubitemid 23182281)